ID   LiPSC-GR1.1
AC   CVCL_RL65
SY   50-001-02A
DR   GEO; GSM1854269
DR   Wikidata; Q54902575
RX   PubMed=26411904;
RX   PubMed=27283945;
CC   From: Lonza, Inc.; Basel; Switzerland.
CC   Population: Hispanic.
CC   HLA typing: A*02,03; B*07,39; C*07,15; DQB1*03,04; DRB1*04,08 (PubMed=27283945).
CC   Omics: Array-based CGH.
CC   Omics: Genome sequenced.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=27283945
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 31.2,33.2
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 18,25
ST   Penta D: 11,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RL66 ! LiPSC-GR1.2
OI   CVCL_RH35 ! ND50038
OI   CVCL_RH36 ! ND50039
OI   CVCL_UX45 ! NH50191
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   PubMed=26411904; DOI=10.1016/j.stemcr.2015.08.015; PMCID=PMC4624993;
RA   Baghbaderani B.A., Tian X.-H., Neo B.H., Burkall A., DiMezzo T.,
RA   Sierra G., Zeng X.-M., Warren K., Kovarcik D.P., Fellner T., Rao M.S.;
RT   "cGMP-manufactured human induced pluripotent stem cells are available
RT   for pre-clinical and clinical applications.";
RL   Stem Cell Reports 5:647-659(2015).
//
RX   PubMed=27283945; DOI=10.1007/s12015-016-9662-8; PMCID=PMC4919381;
RA   Baghbaderani B.A., Syama A., Sivapatham R., Pei Y., Mukherjee O.,
RA   Fellner T., Zeng X.-M., Rao M.S.;
RT   "Detailed characterization of human induced pluripotent stem cells
RT   manufactured for therapeutic applications.";
RL   Stem Cell Rev. Rep. 12:394-420(2016).
//